FDA Still Struggling for Reliable CBD Data; Congress Losing Patience
By EsqSocial Corporation 20/01/20
In late May 2019, the Food and Drug Administration held a landmark hearing regarding a regulatory framework for CBD products. By July, Congress was already becoming impatient with the lack of progress. It is now January 2020, and the FDA does not...
By: Locke Lord LLP